Colgate-Palmolive (CL) Director Acquires 319 Shares at $82.13
Lorrie M. Norrington, a director of Colgate-Palmolive Company (CL), reported a transaction dated 10/01/2025 in which she acquired 319 shares of Colgate common stock at a price of $82.13 per share.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Lorrie M. Norrington, a director of Colgate-Palmolive Company (CL), reported a transaction dated 10/01/2025 in which she acquired 319 shares of Colgate common stock at a price of $82.13 per share. After this transaction she beneficially owned 39,061 shares in a direct ownership form. The filing states the purchase reflects a portion of an annual cash retainer deferred into a stock unit account under the company’s Deferred Compensation Plan for Non-Employee Directors. The Form 4 was signed by an attorney-in-fact on 10/03/2025.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 319 | $82.13 | $26K |
Footnotes (1)
- F1. Portion of annual cash retainer deferred to a stock unit account pursuant to the Deferred Compensation Plan for Non-Employee Directors.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What transaction did Colgate-Palmolive director Lorrie Norrington report (CL)?
When was the Form 4 signed and by whom?
AI-generated analysis. How Rhea-AI works. Not financial advice.